Ir para o conteúdo principal

United StatesÚltimas notícias

Bloomberg

Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly's tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks on "Bloomberg Open Interest."

Leia mais: Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline
Bloomberg

Market Reaction to Tariffs Subdued, BMO CEO Says

Market reaction to the US Supreme Court ruling on tariffs has been subdued, said Bank of Montreal Chief Executive Officer Darryl White. "Part of that is because some of the outcome that we saw over the last few days was probably priced into bond markets, so we haven't seen much of a reaction there," he said on Bloomberg Surveillance.

Leia mais: Market Reaction to Tariffs Subdued, BMO CEO Says
Grafa
Industrials

Stepan reports Q4 net income growth amid mixed EBITDA

Stepan Company (NYSE:SCL), a global manufacturer of specialty chemicals including surfactants, polymers and specialty products for consumer and industrial markets, reported fourth-quarter and full-year 2025 results on February 23, 2026, highlighting resilience in a challenging chemical industry environment marked by raw material volatility and demand fluctuations.

Leia mais: Stepan reports Q4 net income growth amid mixed EBITDA